NCT06195826 is a clinical trial of Gravity infusion in Hysteroscopic Myomectomy, sponsored by Far Eastern Memorial Hospital.

Who is sponsoring NCT06195826?

NCT06195826 is sponsored by Far Eastern Memorial Hospital.

What drugs are being tested in NCT06195826?

Interventions in NCT06195826: Gravity infusion, Pump infusion.

What condition does NCT06195826 study?

NCT06195826 studies Hysteroscopic Myomectomy.

Is NCT06195826 still recruiting?

NCT06195826 is currently status unknown. Last updated 8 January 2024.

Last reviewed 2024-01-08 · How we verify

NCT06195826

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Gravity Versus Pump Infusion of Distending Media for Hysteroscopic Myomectomy

Status unknown Last updated 8 January 2024

What this trial tests

trial testing Gravity infusion in Hysteroscopic Myomectomy in 100 participants. Status unknown.

Timeline

21 November 2023

Primary endpoint
31 December 2024

31 December 2024

Quick facts

Lead sponsor	Far Eastern Memorial Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	21 November 2023
Primary completion	31 December 2024
Estimated completion	31 December 2024
Sites	1 location across Taiwan

Drugs / interventions tested

Gravity infusion
Pump infusion

Conditions studied

Hysteroscopic Myomectomy — all drugs for Hysteroscopic Myomectomy →

Sponsor

Far Eastern Memorial Hospital

Who can join

20 and older, female only, with Hysteroscopic Myomectomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the perioperative outcome between the gravity versus pump infusion groups in women who received hysteroscopic myomectomy

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hysteroscopic Myomectomy

Currently open trials in the same condition.

NCT06150521 — Hysteroscopic Myomectomy for Submucosal Myomas Without Energy Instruments · active not recruiting

Other Far Eastern Memorial Hospital trials

Trials by the same sponsor.

NCT07385976 — The Role of Blood Perfusion in Cervical Cancer, Cervical Intraepithelial Neoplasm and Ovarian Cancer Patients · not yet recruiting
NCT07107542 — Exploring the Relationship Between Mini-Clinical Evaluation Exercise (Mini-CEX) and Entrustable Professional Activities · not yet recruiting
NCT07114653 — The Role of POLE Mutation in High Risk Endometrial Cancer. · recruiting
NCT07105345 — Exploring Efficacy of Multi-Mode Cognitive Processing Therapy (CPT) for PTSD · NA · recruiting
NCT07110350 — Clinical Outcomes of Non-Indicated Staged Laparotomies in Abdominal Trauma · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06195826 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Far Eastern Memorial Hospital
Last refreshed: 8 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06195826.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing